Bionik Laboratories Corp. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q2 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Bionik Laboratories Corp. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q2 2023.
  • Bionik Laboratories Corp. Entity Common Stock, Shares Outstanding for the quarter ending June 16, 2023 was 12.5M shares, a 84.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 12.5M +5.71M +84.4% Jun 16, 2023 10-K 2023-06-21
Q4 2022 6.88M +1.09M +18.8% Feb 3, 2023 10-Q 2023-02-08
Q3 2022 6.77M +977K +16.9% Nov 7, 2022 10-Q 2022-11-09
Q2 2022 6.77M +1.18M +21.1% Jun 6, 2022 10-K 2022-06-09
Q4 2021 5.79M +786K +15.7% Feb 7, 2022 10-Q 2022-02-09
Q3 2021 5.79M +782K +15.6% Nov 8, 2021 10-Q 2021-11-10
Q2 2021 5.59M +580K +11.6% Jun 18, 2021 10-K 2021-06-24
Q4 2020 5M +14.2K +0.29% Feb 10, 2021 10-Q 2021-02-11
Q3 2020 5.01M +38.6K +0.78% Nov 12, 2020 10-Q 2020-11-12
Q2 2020 5.01M +1.31M +35.3% Jun 25, 2020 10-K 2020-06-30
Q4 2019 4.99M +2.65M +113% Feb 3, 2020 10-Q 2020-02-14
Q3 2019 4.97M +2.63M +113% Nov 12, 2019 10-Q 2019-11-14
Q2 2019 3.7M -244M -98.5% Jun 27, 2019 10-K 2019-07-01
Q4 2018 2.34M -53.5M -95.8% Feb 8, 2019 10-Q 2019-02-11
Q3 2018 2.34M -53.5M -95.8% Nov 13, 2018 10-Q 2018-11-13
Q2 2018 248M +199M +407% Jun 25, 2018 10-K 2018-06-27
Q4 2017 55.9M +8.64M +18.3% Feb 13, 2018 10-Q 2018-02-13
Q3 2017 55.9M +9.52M +20.5% Nov 13, 2017 10-Q 2017-11-13
Q2 2017 48.9M +26.2M +115% Jun 25, 2017 10-K 2017-06-29
Q4 2016 47.2M Feb 14, 2017 10-Q 2017-02-14
Q3 2016 46.4M +23.9M +107% Nov 10, 2016 10-Q 2016-11-15
Q2 2016 22.7M +3.76M +19.8% Jun 22, 2016 10-KT 2016-06-30
Q1 2016 22.6M -43.2M -65.7% Mar 11, 2016 10-K 2016-03-18
Q3 2015 22.4M -93.8M -80.7% Nov 10, 2015 10-Q 2015-11-12
Q2 2015 19M -97.3M -83.7% May 20, 2015 10-Q/A 2016-03-17
Q1 2015 65.8M -50.4M -43.3% Apr 15, 2015 10-K 2015-04-15
Q3 2014 116M 0 0% Nov 14, 2014 10-Q 2014-11-14
Q2 2014 116M 0 0% Aug 13, 2014 10-Q 2014-08-14
Q1 2014 116M +111M +2175% Apr 14, 2014 10-K 2014-04-15
Q3 2013 116M Sep 30, 2013 10-Q 2013-11-14
Q2 2013 116M Aug 14, 2013 10-Q 2013-08-14
Q1 2013 5.11M +5.11M +510849900% Mar 6, 2013 10-K 2013-03-06
Q4 2012 4.99M +100 +0% Nov 19, 2012 10-Q 2012-11-19
Q1 2012 1* May 8, 2012 10-Q 2012-05-15
Q4 2011 4.99M Dec 31, 2011 10-K 2012-04-11
Q3 2011 4.9M Sep 30, 2011 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.